There are many factors propelling the ongoing issue, but the fact is diabetes is quickly approaching epidemic levels. Thousands of people worldwide are being diagnosed with the disease. In fact, analysts estimate that treating diabetes could grow to a $2 trillion market by 2030.
Our Best Dividend Stocks List pick in the healthcare sector is at the forefront of treating the disease.
Our chosen firm has parlayed its experience as being one of the largest medical device makers – spanning numerous heart, surgery and other applications – into being a kingpin in diabetes management. The best part is our pick is immune from much of the political pandering that goes along with diabetes care. Because it doesn’t focus on insulin itself, just the delivery methods, its advanced pumps are ignored in much of the punditry about rising prices. Moreover, our pick continues to move into higher-tech and internet-connected glucose readers and pumps. These devices feature higher margins and have continued to boost profits at the firm.
See the original article on our pick here.
And speaking of those profits, our pick’s large portfolio of devices outside of diabetes continues to drive cash flows and revenues. This has long made it a great dividend stock with decades’ worth of dividend growth behind it. With its growing leadership position in diabetes, as well as its huge portfolio of other devices, our pick is poised to keep the growth going.
To summarize, here are five reasons why you should own this stock:
- Operates in over 160 countries with reported revenues of over $30 billion last year, representing a 5.5% year-over-year increase.
- Member of S&P 500 Dividend Aristocrats with a long history of dividend increases and nearly 40 years’ worth of continued raises.
- Huge device portfolio, with a new focus on high-tech/high-margined medical devices.
- Smartly using M&A and asset sales to prune/grow its portfolio into new areas.
- Healthy payout ratio of 42% and growing yield of 2.12%.
Our Best Dividend Stocks List has 20 of the highest-rated stocks by our proprietary rating system. Go Premium to find out the entire list.
